Procter & Gamble vs AB InBev
Procter & Gamble and AB InBev: this page compares business models, financial performance, and market context in a neutral, accessible way. Educational content, not financial advice.
Procter & Gamble and AB InBev: this page compares business models, financial performance, and market context in a neutral, accessible way. Educational content, not financial advice.
Why It's Moving
PG Stock Dips Sharply Amid Mixed Earnings Signals, But Analysts Rally Behind Rebound Potential
- Q2 FY2026 earnings delivered $1.88 EPS versus $1.86 expected, but $22.2B revenue missed $22.34B forecast, with 1% organic growth from pricing offsetting volume dips—yet non-US markets accelerated nearly 3%, signaling underlying strength.
- Analysts turn bullish: UBS lifts target to $170 (Buy), JPMorgan upgrades to Overweight on margin gains and sales acceleration, while BofA and Wells Fargo raise sights, eyeing a stronger H2.
- Buybacks slashed shares 1.4% YTD with healthy cash flow and low debt, bolstering returns as institutions pile in, confirming a potential bottom for compounding upside.
BUD Stock Slides Amid Analyst Buy Calls as Sector Pressures Mount
- Goldman Sachs stuck with its Buy rating on March 20, underscoring BUD's premium brand strength amid market turbulence.
- RBC reaffirmed its Buy stance on March 18, highlighting potential for volume recovery in key markets.
- Shares tumbled 4% on March 20 and continued lower, reflecting broader brewer sector strains like shifting consumer trends.
PG Stock Dips Sharply Amid Mixed Earnings Signals, But Analysts Rally Behind Rebound Potential
- Q2 FY2026 earnings delivered $1.88 EPS versus $1.86 expected, but $22.2B revenue missed $22.34B forecast, with 1% organic growth from pricing offsetting volume dips—yet non-US markets accelerated nearly 3%, signaling underlying strength.
- Analysts turn bullish: UBS lifts target to $170 (Buy), JPMorgan upgrades to Overweight on margin gains and sales acceleration, while BofA and Wells Fargo raise sights, eyeing a stronger H2.
- Buybacks slashed shares 1.4% YTD with healthy cash flow and low debt, bolstering returns as institutions pile in, confirming a potential bottom for compounding upside.
BUD Stock Slides Amid Analyst Buy Calls as Sector Pressures Mount
- Goldman Sachs stuck with its Buy rating on March 20, underscoring BUD's premium brand strength amid market turbulence.
- RBC reaffirmed its Buy stance on March 18, highlighting potential for volume recovery in key markets.
- Shares tumbled 4% on March 20 and continued lower, reflecting broader brewer sector strains like shifting consumer trends.
Investment Analysis
Pros
- Procter & Gamble delivered stable fiscal 2025 results with a 2% organic sales growth and an 8% increase in diluted EPS despite a volatile environment.
- The company expects to continue organic sales growth, EPS growth, and strong free cash flow productivity in fiscal 2026.
- Analyst consensus strongly favours the stock with an average price target around $174, implying about 19% upside from current levels.
Considerations
- Net sales were flat year-over-year in fiscal 2025, indicating challenges in top-line growth.
- Recent insider selling and some lowered price targets suggest cautious sentiment among company insiders and analysts.
- The company's price-to-earnings ratio is relatively high, raising concerns about potential overvaluation.
AB InBev
BUD
Pros
- Anheuser-Busch InBev is the largest global player in alcoholic and non-alcoholic beverage manufacturing and distribution, providing scale advantages.
- The company maintains a significant market capitalization, indicating strong investor backing and liquidity.
- Its extensive brand portfolio and global footprint support diversified revenue streams and resilience against regional downturns.
Considerations
- The alcoholic beverage sector faces regulatory risks and changing consumer preferences that may impact growth.
- Anheuser-Busch InBev is exposed to macroeconomic pressures including inflation and currency fluctuations affecting profitability.
- The company's ADR share price shows limited short-term upside, with relatively modest recent price appreciation.
Related Market Insights
Global Blue-Chips: Could They Reduce Market Risk?
Invest in global blue-chip giants like Microsoft, P&G, & Coca-Cola. Discover how their worldwide operations and defensive traits can reduce market risk and stabilise your portfolio with Nemo.
Aimee Silverwood | Financial Analyst
October 14, 2025
Building Your Child's Future: Why Global Brands Beat Local Bets
Secure your child's financial future. Discover how investing in established global brands offers Brazilian families superior diversification & long-term wealth building. Start with fractional shares.
Aimee Silverwood | Financial Analyst
October 8, 2025
Related Market Insights
Global Blue-Chips: Could They Reduce Market Risk?
Invest in global blue-chip giants like Microsoft, P&G, & Coca-Cola. Discover how their worldwide operations and defensive traits can reduce market risk and stabilise your portfolio with Nemo.
Aimee Silverwood | Financial Analyst
October 14, 2025
Building Your Child's Future: Why Global Brands Beat Local Bets
Secure your child's financial future. Discover how investing in established global brands offers Brazilian families superior diversification & long-term wealth building. Start with fractional shares.
Aimee Silverwood | Financial Analyst
October 8, 2025
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble is expected to release its next earnings report on April 24, 2026 before market open, covering the third quarter of fiscal year 2026. This follows the company's recent Q2 FY2026 earnings release on January 22, 2026, which reported core EPS of $1.88 in line with prior year and organic sales growth of 0%. The upcoming report will provide investors with updated performance metrics and management guidance for the remainder of the fiscal year.
AB InBev (BUD) Next Earnings Date
Anheuser-Busch InBev (BUD) is expected to release its next earnings report on May 4-5, 2026 before market open, covering first quarter 2026 results. The company's earnings call and webcast are scheduled for July 30, 2026 for the second quarter results. Consensus estimates project earnings per share of approximately $0.89 for the upcoming quarter. Please note that the exact announcement date has not been officially confirmed by the company, so investors should monitor official sources for any schedule changes.
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble is expected to release its next earnings report on April 24, 2026 before market open, covering the third quarter of fiscal year 2026. This follows the company's recent Q2 FY2026 earnings release on January 22, 2026, which reported core EPS of $1.88 in line with prior year and organic sales growth of 0%. The upcoming report will provide investors with updated performance metrics and management guidance for the remainder of the fiscal year.
AB InBev (BUD) Next Earnings Date
Anheuser-Busch InBev (BUD) is expected to release its next earnings report on May 4-5, 2026 before market open, covering first quarter 2026 results. The company's earnings call and webcast are scheduled for July 30, 2026 for the second quarter results. Consensus estimates project earnings per share of approximately $0.89 for the upcoming quarter. Please note that the exact announcement date has not been officially confirmed by the company, so investors should monitor official sources for any schedule changes.
Which Baskets Do They Appear In?
Global Blue-Chips: Could They Reduce Market Risk?
Amid local economic fluctuations, many Brazilians are looking to international markets for portfolio resilience and stable growth opportunities. This basket provides exposure to a collection of large, established US and EU-listed multinational companies known for their market leadership.
Published: October 14, 2025
Explore BasketChild Investment Plans Brazil Global Brands 2025
Brazilian families seeking long-term financial stability for the next generation may find opportunities in established international companies. This basket provides exposure through US and EU-listed stocks of globally recognized consumer, technology, and financial brands.
Published: October 8, 2025
Explore BasketWhich Baskets Do They Appear In?
Global Blue-Chips: Could They Reduce Market Risk?
Amid local economic fluctuations, many Brazilians are looking to international markets for portfolio resilience and stable growth opportunities. This basket provides exposure to a collection of large, established US and EU-listed multinational companies known for their market leadership.
Published: October 14, 2025
Explore BasketChild Investment Plans Brazil Global Brands 2025
Brazilian families seeking long-term financial stability for the next generation may find opportunities in established international companies. This basket provides exposure through US and EU-listed stocks of globally recognized consumer, technology, and financial brands.
Published: October 8, 2025
Explore BasketBuy PG or BUD in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Procter & Gamble vs British American Tobacco
Procter & Gamble vs British American Tobacco compares business models, financials and market context to help readers decide which company to research further.
Procter & Gamble vs Honeywell
A factual, neutral comparison of Procter & Gamble and Honeywell examining business models, financial metrics, and market context to help readers decide what to research next.
Procter & Gamble vs General Electric
Procter & Gamble vs General Electric compares business models, financial performance, and market context in a neutral overview, highlighting similarities, differences, and research factors.
